# Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’

> **Newsylist Open Intelligence Dossier** · First detected: 2026-08-09 19:29 UTC · Category: Health · Sources: 10 · Current Velocity: 7.91

## Intelligence Brief
"Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’" developed substantial multi-source reporting across the Health sector, tracked across 10 distinct newsrooms by Newsylist.


Key reporting was led by Standard-Examiner, Oncodaily, Medscape and onclive.com. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.


Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.

## Verified Facts & Key Claims
### What drove coverage for Patients in Illinois starting to receive experimental pancreatic cancer dru?
Coverage spiked when 10 independent newsrooms published 10 verified reports during this coverage cycle.

### How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Standard-Examiner | Intermountain Hospitals in Ogden, Layton to be among first to administer new pancreatic cancer drug | 2026-08-12 18:19 | [Source Link](https://news.google.com/rss/articles/CBMi2AFBVV95cUxQZmlpVzNLSkk5YmZMMFFxQTNoNFpsTXk2V3JYTUhsdVhCZjJNYWRXOVFSQ0RMd1ltRDkwWmpxWlJubHptLS1rc3I5X2hMRjlCRmMzaGZwYmVMODExM1cxdEZNSHZEYWI5UnNLS2NCX0RYeXJNZXdwME50cXFUdVlPQ2VrWkRwWHluSHB4a3VUWml6aER2X3doX3lCeFIxZERWaW9LNzRUYWphclFOZXRfSERPMlVzQm5mTGVnYXRnd3hDVFY4OG9aOWRoUkZ0UG56UXNudzNTNDg?oc=5) |
| Oncodaily | Arturo Loaiza-Bonilla: Daraxonrasib Brings New Hope to Pancreatic Cancer Patients | 2026-08-12 18:19 | [Source Link](https://news.google.com/rss/articles/CBMiaEFVX3lxTE9Da2cxc3d0THoxRUQxazQ5X1BZOXRkUmwzWkJPUnV3QkRIYnJLOTdsYURrdF9CV0xSSGdLVWFySFVBNDdlaGJUTDZpR240QU1XbUlaRHhqeUlQVGlXdl9NeGxlOGhBcU5y?oc=5) |
| Medscape | Pancreatic Cancer Specialists Getting a Jump on Daraxonrasib | 2026-08-09 11:00 | [Source Link](https://news.google.com/rss/articles/CBMiqAFBVV95cUxQTHpBcjlfaU84ZHpGZkczeGgyUHptTjFEc2hoYnlsMXRpeEY4enppdXRaY19DckZPVjNlRHlDZG5QTmd1UUotR192MVp3bDlHbDNrQVdTdkstZ3gxMERJZ3dxbENjMzlGVVBIM2VjZ0lUV0JMQVVONHRvbGRMZVhzb2h2R3IwRXZGN29WUFFYQndVdzNnNkNlaWpqRm50bzBYWng1cjRPc0U?oc=5) |
| onclive.com | Cracking the KRAS Code: Daraxonrasib's Practice-Changing Data in Pancreatic Cancer and Beyond | 2026-08-09 11:00 | [Source Link](https://news.google.com/rss/articles/CBMivgFBVV95cUxPSnNmLW1ndVRqZjZmVTlqQmh0UDdBSXNaT1dWZlVjSjdlLWZRN0IySHFtMnprYnA1VmhQUHN1aDJ3TlNfTjFCTExNM3Z6QmFIOUVsOFFKQ25rdzlLUUdxdkhBT2UzVzVLNlhwVXUyeElEMmlpVG9jeFNqMXpmX3lNZlpzcXdYcXZyNUZHQmc4b1FnNGdFT0R0RDAybFRlSjhMLVBxTjdGM1ZpaFpwSTZmb292cHRSci01MnY4NlpB?oc=5) |
| Stanford Medicine | Stanford expands access to revolutionary pancreatic cancer drug | 2026-08-09 11:00 | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxPcnFPQzY4YlgxSndiM3BlNHRCeXdxcVRRNjhfVHJSbUZBbXRRSHlHeGg0bS1UMTF0OTdQU3VnTnZMVUliMXZ3RXpMdGkxZkJLMTd5OXVzSEM0Y2hkTldmdTVfdzdwWFhMbV9GRU5heXZLb3lsZWhIZUlfVG5YZ0xfNmNPdC1QMWZ4MFcxcEJ3R0pjSGozUm1FR1dfck1YendVZmJCZzJZUHJSa2I3aHdlbw?oc=5) |
| News-Medical | New drug delivers promising survival gains in pancreatic cancer | 2026-08-09 11:00 | [Source Link](https://news.google.com/rss/articles/CBMisAFBVV95cUxOaEJscGw5RVlqcHFlLVk1ZlpYTWNwRkM2NENwSUJsejNhUW9xMnJ6YkZGNVNPcnJVR2hOQlBnZEl1M3hMeXhhdnFpRzNJQ0gzSEVid0FSa21VSEtHNzRfVlYwNWNCb1B5MW43ME5jMHdFZ2pqUlp6M2pTT3Fzblh0anprMmZVcWVId0FqbF9VX1VkdWUzcEJfdUdWUlFZbnUzaTJGb28ydmFpZ1J1cV9XeQ?oc=5) |
| The Clinical Trial Vanguard | FDA Accepts daraxonrasib Application for RAS-Mutant Pancreatic Cancer | 2026-08-09 11:00 | [Source Link](https://news.google.com/rss/articles/CBMiswFBVV95cUxQcHF5VlJQX2RCVUI0djFsbG5GS2NZRXJXQlZwY3R0OE90cHNwSDZTQzFMbVlxTG83eHVYZUdjUk1wdDA3SGVKUzBhZ24wYzJmdUpTN25jbXhDRmozaU5HdTg4eThhY2xxcXAxdndHZGRvWUNFMC0yRkk3MkNJemFual8xMnZ6RTVZT2lWUTFQR3ZncTVVX1QzSW5hQldwTWJ4bUZEdDlKZUM0S2ZGV0VGQmowbw?oc=5) |
| University of Utah Health | Breakthrough Drug Brings Hope to Utah Grandfather with Pancreatic Cancer | 2026-08-09 11:00 | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxPcG85YlVwajZPMy1zMlFOQzNRZVAyaTBKRE5tRXlQODFNTHlRRWMxZnFmal85UEg1a1hrWnZqaDQ0XzBBS0t1ODRrMThlZUcxWWxqdDJPY2RNRmd6cldxbEMzdXNiaFRkOUZ1Zm1DMERKbjZOUWJmeEV5ZDBXS1N0ajdPUEtVcFhTY1NDRHk1eFRKNHhjeVhBN0tn?oc=5) |
| NH Business Review | Letter to the editor: Good news for patients | 2026-08-09 11:00 | [Source Link](https://news.google.com/rss/articles/CBMinwFBVV95cUxNQVFRb2xXS29KMHJoZ2llR0J6ODNOOFhScjZPaDBjZUU0TjZSMDluZ2FNam5XcU5Wci1pX0h6aG0xbldSMkhENHdnTkhqNTd2T3lEcWZMcVhBM2Y2OG1ZVERkeXE3UG5RaUQ3U2stbGlBMDFDcmhSTEtwS0F2N3JhUkJuSjEwd2M0Z0VkMWdyR2NEMUVkaTBLMmFEZ3ZFM2M?oc=5) |
| chicagotribune.com | Patients in Illinois starting to receive experimental pancreatic cancer drug: ‘Game changer’ | 2026-08-09 11:00 | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxQTW9TVFZIVGJ0TVpNSWh5WXpVSXBVNEYycVdMX25KR1pXak9UNjFDQzc4TWs3QzY0UjIwaUVqWGNhTTNMOElGOWQ5bkdPeGJ0UlJTRmNyNmJSTkFVdXR6dk5KVlAtTWJSd2c4V0hpRnV2dURRZW1aZTNsSUpscDhRQUVBMXM?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-08-09/patients-in-illinois-starting-to-receive-experimental-pancreatic-cancer-drug*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*